Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Highly Accessed Research article

Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer

Chen-Yun Yeh1, Shin-Mei Shin1, Hsuan-Heng Yeh3, Tsung-Jung Wu2, Jyh-Wei Shin4, Tsuey-Yu Chang4, Giri Raghavaraju1, Chung-Ta Lee2, Jung-Hsien Chiang5, Vincent S Tseng5, Yuan-Chii G Lee7, Cheng-Huang Shen8, Nan-Haw Chow26 and Hsiao-Sheng Liu16*

Author Affiliations

1 Department of microbiology and immunology, College of medicine, National Cheng Kung University, Tainan, Taiwan

2 Department of pathology, College of medicine, National Cheng Kung University, Tainan, Taiwan

3 Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan

4 Department of parasitology, College of medicine, National Cheng Kung University, Tainan, Taiwan

5 Department of computer science and information engineering, National Cheng Kung University, Tainan, Taiwan

6 Center for gene regulation and signal transduction research, National Cheng Kung University, Tainan, Taiwan

7 Graduate Institute of Medical Informatics, Taipei Medical University, Taipei, Taiwan

8 Department of Urology, Chia-Yi Christian Hospital, Chia-Yi, Taiwan

For all author emails, please log on.

BMC Cancer 2011, 11:139  doi:10.1186/1471-2407-11-139

Published: 16 April 2011



A cross-talk between different receptor tyrosine kinases (RTKs) plays an important role in the pathogenesis of human cancers.


Both NIH-Met5 and T24-Met3 cell lines harboring an inducible human c-Met gene were established. C-Met-related RTKs were screened by RTK microarray analysis. The cross-talk of RTKs was demonstrated by Western blotting and confirmed by small interfering RNA (siRNA) silencing, followed by elucidation of the underlying mechanism. The impact of this cross-talk on biological function was demonstrated by Trans-well migration assay. Finally, the potential clinical importance was examined in a cohort of 65 cases of locally advanced and metastatic bladder cancer patients.


A positive association of Axl or platelet-derived growth factor receptor-alpha (PDGFR-α) with c-Met expression was demonstrated at translational level, and confirmed by specific siRNA knock-down. The transactivation of c-Met on Axl or PDGFR-α in vitro was through a ras- and Src-independent activation of mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK/ERK) pathway. In human bladder cancer, co-expression of these RTKs was associated with poor patient survival (p < 0.05), and overexpression of c-Met/Axl/PDGFR-α or c-Met alone showed the most significant correlation with poor survival (p < 0.01).


In addition to c-Met, the cross-talk with Axl and/or PDGFR-α also contributes to the progression of human bladder cancer. Evaluation of Axl and PDGFR-α expression status may identify a subset of c-Met-positive bladder cancer patients who may require co-targeting therapy.

Axl; PDGFR-α; c-Met; bladder cancer